Prostreat Seen as Better Than Current Therapies at Stopping Aggressive Prostate Cancer in Mice July 9, 2018 NucleoBio’s investigative therapy Prostreat was seen to be better at preventing the growth and spread of metastatic castration-resistant prostate cancer than currently available hormone therapies, a mouse study showed. The treatment was effective even in cells with a variant of the androgen receptor that renders them resistant to treatment.Read more.Source: Prostate Cancer News Today Prostate Cancer News
NucleoBio’s investigative therapy Prostreat was seen to be better at preventing the growth and spread of metastatic castration-resistant prostate cancer than currently available hormone therapies, a mouse study showed. The treatment was effective even in cells with a variant of the androgen receptor that renders them resistant to treatment.Read more.Source: Prostate Cancer News Today
